Madrigal Pharmaceuticals Inc (MDGL) returns
Madrigal Pharmaceuticals returns over 10 years
$1,000 invested in Madrigal Pharmaceuticals ten years ago was worth $25,556 at the close on October 30, 2026, with dividends reinvested: an average return of 38.3% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -14.6% | — | $853.96 | -0.9% |
| 3 months | -12.7% | — | $872.75 | +2.1% |
| Year to date | -26.1% | — | $739.02 | +11.7% |
| 1 year | +0.7% | — | $1,007 | +12.4% |
| 3 years | +241.1% | +50.5% | $3,411 | +88.5% |
| 5 years | +453.5% | +40.8% | $5,535 | +76.0% |
| 10 years | +2,456% | +38.3% | $25,556 | +316.6% |
Madrigal Pharmaceuticals return by calendar year
| Year | MDGL | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -26.1% | +11.7% | -37.8% |
| 2025 | +88.7% | +17.7% | +71.0% |
| 2024 | +33.4% | +24.9% | +8.5% |
| 2023 | -20.3% | +26.2% | -46.5% |
| 2022 | +242.5% | -18.2% | +260.7% |
| 2021 | -23.8% | +28.7% | -52.5% |
| 2020 | +22.0% | +18.4% | +3.6% |
| 2019 | -19.2% | +31.2% | -50.4% |
| 2018 | +22.8% | -4.6% | +27.4% |
| 2017 | +516.0% | +21.7% | +494.3% |
| 2016 | +20.9% | +12.0% | +8.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Madrigal Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.